Paper42897656PubMed
ZRANB1-mediated EZH2 stabilization drives S100B/S100A4 transcriptional activation and corneal neovascularization in alkali burns.
Liu F and 5 others. Biol Direct, 2026.
Cite this record
ConductScience Library. ZRANB1-mediated EZH2 stabilization drives S100B/S100A4 transcriptional activation and corneal neovascularization in alkali burns. Papers, record 42897656. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42897656
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- ZRANB1-mediated EZH2 stabilization drives S100B/S100A4 transcriptional activation and corneal neovascularization in alkali burns.
- Journal
- Biol Direct
- Year
- 2026
- Publication types
- Journal Article
- Revised in PubMed
- 2026-10-22
Source PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Enhancer of Zeste Homolog 2 Protein | Major topic |
| S100 Calcium-Binding Protein A4 | Major topic |
| Corneal Neovascularization | Major topic |
| Burns, Chemical | Major topic |
| S100 Calcium Binding Protein beta Subunit | Major topic |
| Eye Burns | Major topic |
| RNA-Binding Proteins | Major topic |
| Animals | |
| Mice | |
| Humans | |
| Transcriptional Activation | |
| Alkalies | |
| Male | |
| Mice, Inbred C57BL | |
| Phosphatidylinositol 3-Kinases | |
| Forkhead Box Protein O3 |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 202310207 | Science and Technology Plan of Jiangxi Provincial Health Commission | PubMed | ||
| 82060174 | Project of Regional Science Foundation of National Natural Science Foundation | PubMed |
Source PubMed
References54
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29971947 | Astragaloside IV modulates TGF-β1-dependent epithelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis. | J Cell Mol Med | 2018 | https://conductscience.org/library/papers/29971947 | PubMed |
| 2 | 36989713 | Successful restoration of corneal surface integrity with a tissue-engineered allogeneic implant in severe keratitis patients. | Biomed Pharmacother | 2023 | https://conductscience.org/library/papers/36989713 | PubMed |
| 3 | 21860419 | FOXO3a represses VEGF expression through FOXM1-dependent and -independent mechanisms in breast cancer. | Oncogene | 2012 | https://conductscience.org/library/papers/21860419 | PubMed |
| 4 | 19907029 | Role of the ubiquitin-proteasome pathway in downregulation of the gap-junction protein Connexin43 by TNF-{alpha} in human corneal fibroblasts. | Invest Ophthalmol Vis Sci | 2010 | https://conductscience.org/library/papers/19907029 | PubMed |
| 5 | 34917084 | Infectious Keratitis: An Update on Role of Epigenetics. | Front Immunol | 2021 | https://conductscience.org/library/papers/34917084 | PubMed |
| 6 | 35345831 | Pharmacological Inhibition of Glutaminase 1 Attenuates Alkali-Induced Corneal Neovascularization by Modulating Macrophages. | Oxid Med Cell Longev | 2022 | https://conductscience.org/library/papers/35345831 | PubMed |
| 7 | 38815785 | Inhibiting PRMT1 protects against CoNV by regulating macrophages through the FGF2/PI3K/Akt pathway. | Eur J Pharmacol | 2024 | https://conductscience.org/library/papers/38815785 | PubMed |
| 8 | 33308321 | Post-translational modifications of EZH2 in cancer. | Cell Biosci | 2020 | https://conductscience.org/library/papers/33308321 | PubMed |
| 9 | 37530328 | Expression of EZH2 and H3K27me3 predicts tumor biology of urothelial carcinoma. | Indian J Pathol Microbiol | 2023 | https://conductscience.org/library/papers/37530328 | PubMed |
| 10 | 22898649 | Corneal neovascularization: an anti-VEGF therapy review. | Surv Ophthalmol | 2012 | https://conductscience.org/library/papers/22898649 | PubMed |
| 11 | 32926102 | S100A4 Silencing Facilitates Corneal Wound Healing After Alkali Burns by Promoting Autophagy via Blocking the PI3K/Akt/mTOR Signaling Pathway. | Invest Ophthalmol Vis Sci | 2020 | https://conductscience.org/library/papers/32926102 | PubMed |
| 12 | 37729973 | Transcription factor TEAD4 facilitates glycolysis and proliferation of gastric cancer cells by activating PKMYT1. | Mol Cell Probes | 2023 | https://conductscience.org/library/papers/37729973 | PubMed |
| 13 | 32562311 | Inhibition of EZH2 alleviates angiogenesis in a model of corneal neovascularization by blocking FoxO3a-mediated oxidative stress. | FASEB J | 2020 | https://conductscience.org/library/papers/32562311 | PubMed |
| 14 | 32042339 | UCH-L1-mediated Down-regulation of Estrogen Receptor α Contributes to Insensitivity to Endocrine Therapy for Breast Cancer. | Theranostics | 2020 | https://conductscience.org/library/papers/32042339 | PubMed |
| 15 | 28479848 | Inhibitory effects of S100A4 gene silencing on alkali burn-induced corneal neovascularization: an in vivo study. | Mol Vis | 2017 | https://conductscience.org/library/papers/28479848 | PubMed |
| 16 | 34751438 | SIRT1-mediated deacetylation of FOXO3a transcription factor supports pro-angiogenic activity of interferon-deficient tumor-associated neutrophils. | Int J Cancer | 2022 | https://conductscience.org/library/papers/34751438 | PubMed |
| 17 | 17502350 | Integration of estrogen and Wnt signaling circuits by the polycomb group protein EZH2 in breast cancer cells. | Mol Cell Biol | 2007 | https://conductscience.org/library/papers/17502350 | PubMed |
| 18 | 40383160 | Cannabidiol-loaded hydrogel contact lenses for on-demand pH regulation and enhanced corneal alkali burn repair. | J Control Release | 2025 | https://conductscience.org/library/papers/40383160 | PubMed |
| 19 | 41121132 | Transforming corneal alkali burn treatment: unveiling mechanisms and pioneering therapies from bench to bedside. | J Transl Med | 2025 | https://conductscience.org/library/papers/41121132 | PubMed |
| 20 | 37458071 | The role of EZH2 in ocular diseases: a narrative review. | Epigenomics | 2023 | https://conductscience.org/library/papers/37458071 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42897656
GET https://conductscience.org/api/papers/v1/42897656/references?page=2